Takeda diabetes drug cuts heart attacks
Key points
- Giving Diabetes patients Takeda Pharmaceutical Co.
- A 5,200-patient clinical study found that Actos, when added to standard therapy, reduced the combined risk of Heart Attacks, Strokes and death by 16 percent in high-risk people with Type 2 diabetes, compared to conventional therapy alone.
- Actos, which is co-promoted by Eli Lilly and Co., belongs to a class of medicines called insulin sensitisers that also includes GlaxoSmithKline Plc's Avandia.
- They work by making the body's cells more sensitive to insulin, thereby helping people with type II, or adult-onset, diabetes to better use their own natural insulin.
Giving Diabetes patients Takeda Pharmaceutical Co. Ltd.'s drug Actos not only lowers their blood sugar levels but also protects them from heart attacks, researchers said on Monday.
A 5,200-patient clinical study found that Actos, when added to standard therapy, reduced the combined risk of Heart Attacks, Strokes and death by 16 percent in high-risk people with Type 2 diabetes, compared to conventional therapy alone.
Actos, which is co-promoted by Eli Lilly and Co., belongs to a class of medicines called insulin sensitisers that also includes GlaxoSmithKline Plc's Avandia.
They work by making the body's cells more sensitive to insulin, thereby helping people with type II, or adult-onset, diabetes to better use their own natural insulin.
The results of the trial on Actos, which is known by the chemical name pioglitazone, were presented at the European Association for the Study of Diabetes congress in Athens.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsMayo Clinic Wins Grant to Gauge Genetic Risk of Heart Attacks, Adverse Drug Reactions
Mayo Clinic researchers will receive more than $3 million in a four-year grant from the National Human Genome Research Institute to translate recent genomic discoveries into tools for individualized medicine. Recent…
20 August 2011
NewsHigher daily dose of aspirin could play key role in preventing heart attacks for those with diabetes
(Edmonton, Canada) In some cases, an apple a day may keep the doctor away, but for people with diabetes, regular, over-the-counter Aspirin may also do the job. A new study by University of Alberta researcher Scot…
6 July 2011
NewsDoctors rush to heart procedure before proven drugs
Fewer than half of Americans with stable heart disease get guideline-recommended medicines before being rushed off for an invasive heart procedure, researchers said Tuesday. Yet the costly procedure, called percutaneous…
